MedTrace Logo

Immunity After Two Doses of Yellow Fever Vaccine

NCT02572518 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 440

Last updated 2015-10-12

No results posted yet for this study

Summary

To evaluate the immune status of yellow fever in adults with a history of two or more doses of vaccine, having received the second dose for at least 1 year, compared to re-vaccinated individuals (second dose) after 30 days.

Conditions

  • Yellow Fever

Sponsors & Collaborators

  • The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)

    lead OTHER

Principal Investigators

  • T G N · Institute of Technology in Immunobiology Bio-Manguinhos/Fiocruz

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02572518 on ClinicalTrials.gov